» Articles » PMID: 23083736

Genetic Removal of P70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2012 Oct 23
PMID 23083736
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X syndrome (FXS) is the leading inherited cause of autism and intellectual disability. Aberrant synaptic translation has been implicated in the etiology of FXS, but most lines of research on therapeutic strategies have targeted protein synthesis indirectly, far upstream of the translation machinery. We sought to perturb p70 ribosomal S6 kinase 1 (S6K1), a key translation initiation and elongation regulator, in FXS model mice. We found that genetic reduction of S6K1 prevented elevated phosphorylation of translational control molecules, exaggerated protein synthesis, enhanced mGluR-dependent long-term depression (LTD), weight gain, and macro-orchidism in FXS model mice. In addition, S6K1 deletion prevented immature dendritic spine morphology and multiple behavioral phenotypes, including social interaction deficits, impaired novel object recognition, and behavioral inflexibility. Our results support the model that dysregulated protein synthesis is the key causal factor in FXS and that restoration of normal translation can stabilize peripheral and neurological function in FXS.

Citing Articles

Trinucleotide repeat expansion and RNA dysregulation in fragile X syndrome: emerging therapeutic approaches.

Jung S, Richter J RNA. 2024; 31(3):307-313.

PMID: 39725461 PMC: 11874960. DOI: 10.1261/rna.080270.124.


A Two-Hit Approach Inducing Flurothyl Seizures in Fmr1 Knockout Mice Impacts Anxiety and Repetitive Behaviors.

Blandin K, Narvaiz D, Sullens D, Womble P, Hodges S, Binder M Brain Sci. 2024; 14(9).

PMID: 39335388 PMC: 11429635. DOI: 10.3390/brainsci14090892.


Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.

Yang Q, Zhou X, Ma T Neurobiol Aging. 2024; 140:116-121.

PMID: 38763076 PMC: 11179164. DOI: 10.1016/j.neurobiolaging.2024.05.009.


Editorial: Molecular links between mitochondrial damage and human neurodegenerative disorders, volume II.

Imai Y Front Cell Dev Biol. 2024; 12:1417802.

PMID: 38742140 PMC: 11089466. DOI: 10.3389/fcell.2024.1417802.


Astroglial Kir4.1 potassium channel deficit drives neuronal hyperexcitability and behavioral defects in Fragile X syndrome mouse model.

Bataveljic D, Pivonkova H, de Concini V, Hebert B, Ezan P, Briault S Nat Commun. 2024; 15(1):3583.

PMID: 38678030 PMC: 11055954. DOI: 10.1038/s41467-024-47681-y.


References
1.
Jin P, Zarnescu D, Ceman S, Nakamoto M, Mowrey J, Jongens T . Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004; 7(2):113-7. DOI: 10.1038/nn1174. View

2.
Melko M, Bardoni B . The role of G-quadruplex in RNA metabolism: involvement of FMRP and FMR2P. Biochimie. 2010; 92(8):919-26. DOI: 10.1016/j.biochi.2010.05.018. View

3.
Magnuson B, Ekim B, Fingar D . Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2011; 441(1):1-21. DOI: 10.1042/BJ20110892. View

4.
Veeraragavan S, Bui N, Perkins J, Yuva-Paylor L, Paylor R . The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide. Behav Neurosci. 2011; 125(5):783-90. PMC: 3183989. DOI: 10.1037/a0025202. View

5.
Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell G . S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem. 2008; 283(27):18478-82. PMC: 2441545. DOI: 10.1074/jbc.C800055200. View